Compounds > rubitecan
Page last updated: 2024-08-24

rubitecan and Carcinoma, Small Cell

rubitecan has been researched along with Carcinoma, Small Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baron, B; Daugaard, G; de Jonge, MJ; Fiedler, W; Fumoleau, P; Lacombe, D; Monfardini, S; Punt, CJ1

Trials

1 trial(s) available for rubitecan and Carcinoma, Small Cell

ArticleYear
RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development Group.
    European journal of cancer (Oxford, England : 1990), 2004, Volume: 40, Issue:9

    Topics: Aged; Antineoplastic Agents; Camptothecin; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Treatment Failure

2004